Goldman Sachs expects widespread Covid vaccination in major economies by June

The top question for the global economy is how quickly people will be given an effective vaccine against Covid-19, reducing the need for job- and business-destroying lockdowns. Economists at Goldman Sachs thinks large swaths of the populations in developed countries will be vaccinated by the middle of next year. In the US, high-risk groups will probably start receiving doses of a vaccine by the middle of next month, which could provide substantial public health benefits by March, according to a research note by Goldman economists led by Jan Hatzius and Daan Struyven.